Articles by Kan Hyeong-woo
Kan Hyeong-woo
hwkan@heraldcorp.com-
Naver’s webtoon dominance continues
South Korean IT giant Naver’s webtoon business is continuing its dominance in the global market, getting recognized as the world’s best webtoon application while posting a record high number of users. Naver Webtoon has been honored as the world’s best webtoon application in the mobile app market by analyzer Sensor Tower’s 2021 Asia-Pacific Awards, the company said Friday. Sensor Tower said Naver Webtoon is the most successful webtoon application in Asia, adding that i
Industry Feb. 20, 2022
-
[Weekender] Investing in the metaverse: Look before you leap
Touted as the next big thing, the metaverse has been undeniably the talk of the global town since last year. The metaverse frenzy accelerated further when Facebook changed its name to Meta in October. Hoping to take the lead in the new online virtual world, all sectors regardless of their specializations have jumped on the metaverse bandwagon. This has led to lofty projections luring individual investors. The global metaverse market is forecast to reach $829 billion (993 trillion won) in 202
Market Feb. 19, 2022
-
Auction for additional 5G spectrum band delayed
The auction for an additional 5G spectrum band, which was slated to take place sometime this month, will be delayed over the remaining differences between the country’s three largest telecommunication companies, officials said Thursday. Earlier in the day, the Science and ICT minister and CEOs of SK Telecom, KT and LG Uplus met at the Seoul Central Post Office to discuss the ongoing dispute of the 5G spectrum auction, but failed to come to a conclusion. After the meeting, Hwang Hyun-si
Industry Feb. 17, 2022
-
Philip Morris Korea’s new parental leave policy 'respects all forms of families'
Philip Morris Korea has implemented a new parental leave policy to support all forms of families raising children including adoptive parents and legal guardians, the company said Wednesday. Under the company’s parental policy, which became effective last month, employees can take up to 126 days of paid parental leave if they are primary caregivers. The company allows up to 56 days of paid parental leave for secondary caregivers. According to the company, a primary caregiver is the perso
Industry Feb. 16, 2022
-
SK Bioscience secures $31m chickenpox vaccine deal with Pan-America
SK Bioscience has signed a $31 million (37 billion won) order to ship out its chickenpox vaccine Sky Varicella to the Pan American Health Organization, the company said Monday. The PAHO, along with the UNICEF, has one of the largest demand for vaccines in the world as it is responsible for supplying mass-scale vaccines on behalf of countries in the central and southern American regions. According to SK Bioscience, the order marked the first time the company succeeded in winning a bid with PAHO
Industry Feb. 14, 2022
-
Kakao leaders desperate to win back investor trust
Kakao leaders are struggling to restore the platform giant’s brand image and win back the trust of investors after the company’s friendly reputation took a huge hit over a series of mishaps. “Looking back on the path that Kakao has walked on over the past four years, Kakao has achieved rapid growth with the support of the entire nation. But in the process, we have suffered growing pains and lost the society’s trust so I feel heavily responsible for it,” Yeo Min-so
Industry Feb. 11, 2022
-
Smilegate launches CrossfireX for next-generation consoles
Smilegate has launched first-person shooting game CrossfireX for next-generation consoles, the company said Thursday. Smilegate said the launch signals the beginning of the company’s plan to target the global console market and solidify its position as South Korea’s representative powerhouse for intellectual property. CrossfireX became available on Xbox One as well as Xbox Series S and X as of 9 a.m. Korea time on Thursday. The video game is provided in nine languages for the tex
Industry Feb. 10, 2022
-
Meet Omnipod, LG's self-driving concept car
LG’s future mobility concept car the LG Omnipod on Thursday made its offline debut at a technology conference organized by Kakao Mobility in Seoul. LG Omnipod, which was first presented in a video at the Consumer Electronics Show in Las Vegas last month, is a concept model of futuristic vehicles that can reconstruct the passengers’ space for various purposes. With the modular in-vehicle appliances and adaptive interior, LG Omnipod can be an office or personal space where users can
Industry Feb. 10, 2022
-
SK Bioscience rolls out 1st batch of Novavax vaccine
SK Bioscience rolled out the first batch of Nuvaxovid, Novavax’s synthetic antigen-based COVID-19 vaccine, the company said Wednesday. On top of the 840,000 doses that were rolled out on Wednesday, SK Bioscience said it plans to supply a total of 2 million doses by the end of this month. The shipment follows the Ministry of Food and Drug Safety’s approval of the vaccine last month. In December, SK Bioscience signed a contract with the US bio firm to secure the manufacturing and s
Industry Feb. 9, 2022
-
Virus surge raises self-test shortage fears
The recent surge in the number of COVID-19 cases has increased the demand for self-test kits, and is causing alarm as there are signs of another supply shortage reminiscent of the mask scarcity seen two years ago. Sales of self-test kits at convenience stores have soared since Jan. 26 when the country’s daily confirmed cases broke 10,000 for the first time. Some stores quickly ran out of stock as the supply could not keep up. A similar pattern has been seen at pharmacies. “Since
Social Affairs Feb. 8, 2022
-
Samsung Biologics scoops up all 6 CMO Leadership Awards
Samsung Biologics has won the 2022 CMO Leadership Awards in all six performance categories of capabilities, compatibility, expertise, reliability, quality and service, the company said Tuesday. The awards, presented by Life Science Leader, Outsourced Pharma and Industry Standard Research, recognize the world’s top contract manufacturing organizations based on ratings and feedback from companies that utilize outsourcing services. The latest recognition marked the ninth consecutive year
Industry Feb. 8, 2022
-
SK Bioscience logs record high sales
SK Bioscience saw record sales of 929 billion won ($774 million) and operating profits of 474 billion won from last year, on the back of strong businesses in its contract manufacturing of the AstraZeneca and Novavax COVID-19 vaccines, the company said Monday. Compared to 2020 yearly figures, SK Bioscience’s annual sales and operating profits went up by 311 percent and 1,158 percent, respectively. About half of the annual numbers came in the fourth quarter alone as the company logged 451
Industry Feb. 7, 2022
-
Celltrion’s COVID-19 treatment gets safety nod in Australia
Celltrion has confirmed the safety of its inhalable antibody treatment for COVID-19 in a phase one clinical trial in Australia, the pharmaceutical company said Monday. Celltrion’s US partner Inhalon Biopharma completed the planned administering of the drugs for 24 volunteers after it acquired testing approval from the Australian Therapeutic Goods Administration in August. The results of the clinical trial proved the drug’s safety, as there were no serious adverse events from inha
Industry Feb. 7, 2022
-
Game developers brace for new industry safety law
Korea’s major game developers are taking preemptive measures to cope with the new industrial safety law and prevent another “crunch mode” controversy. Under the Serious Accident Punishment Act, which took effect from Jan. 27, business owners can face a minimum prison term of one year or a fine of up to 1 billion won ($835,000) if a fatal accident at the workplace causes a death or more than one injured person. The punishment depends on whether the owners are found guilty of n
Industry Feb. 6, 2022
-
Why aren't there Korean-made vaccines yet?
Although it has been over two years since the coronavirus began spreading in Korea, the country has not seen a homemade vaccine developed yet. SK Bioscience is the company closest to delivering the first Korean-developed vaccine as the biopharmaceutical firm’s GBP510 is in the third and final phase of clinical trials. The government and company officials have voiced hope for a successful result and swift authorization as well as commercialization of GBP510 in the first half of this year,
Industry Feb. 2, 2022
Most Popular
-
1
Yoon apologizes for first lady Dior bag scandal, calls push for special probe ‘political’
-
2
Korea forecast to overtake Taiwan in chip production by 2032: report
-
3
Girl hanging on bridge, police trying to rescue her both fall off; rescued immediately
-
4
[K-pop’s dilemma] Can K-pop break free from ‘fandom’ model?
-
5
YouTuber fatally stabbed on livestream by another YouTuber in Busan
-
6
Yoon rebuffs opposition's call for special probe into wife
-
7
No plan to let doctors with foreign licenses practice here anytime soon: PM
-
8
Stray Kids hit with racism in Met Gala photo line
-
9
[News Analysis] Yoon's first 2 years marked by intense confrontations, lack of leadership
-
10
Yoon apologizes for wife's 'unwise conduct'